Cadrenal Therapeutics Inc CVKD

$1.00 -0.08 (-7.86%)

Valuation

Market cap
3,889,000
Revenue TTM
$0
Net income TTM
$-13,240,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
85,628
Avg volume
522,310
Day's range
$0.97 – $1.09
Shares out
3,568,000
Stochastic %K
10%
Beta
1.82
Analysts
Strong Sell
Price target
$14.00

Price

Company profile

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions. The company is developing Tecarfarin, an oral vitamin K antagonist that is in Phase 3 clinical trial designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation, such as patients with left ventric...

Show more

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions. The company is developing Tecarfarin, an oral vitamin K antagonist that is in Phase 3 clinical trial designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, and atrial fibrillation; CAD-1005, a first-in-class 12-LOX inhibitor for the treatment of heparin-induced thrombocytopenia, a deadly immune-mediated thrombotic disorder that has completed Phase 2 clinical trial; and Frunexian, a parenteral clinical-stage factor XIa inhibitor designed for use in acute hospital settings that has completed Phase 1 clinical trial. It has a collaboration agreement with Abbott Global Enterprises Limited to evaluate the efficacy and safety of Tecarfarin in patients with a left-ventricular assist device. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.

Industry
Biotechnology
Sector
Healthcare
Phone
904 300 0701
Website
https://www.cadrenal.com
Address
822 A1A North, Suite 306, Ponte Vedra, United States

Latest news

Stocktwits

LuckyEnzo Oct 1, 8:48 AM
@EquivalentExchange is on an absolute tear recently🔥the plays just keep getting better! If you’re not following yet you’re missing out. $RUBI $CHSN $CVKD soon-
0 replies
GladiatorPicks Sep 30, 5:23 PM
$CVKD Just flicked green , someone buying?
1 replies
Tghhg Sep 29, 4:21 AM
$CVKD
0 replies
topstockalerts Sep 27, 9:41 PM
After Hours Top Gainers PT2 $DFSC $ACET $CVKD $OMEX $MTUS
0 replies
topstockalerts Sep 26, 11:47 AM
After Hours Top Gainers PT2 $DFSC $ACET $CVKD $OMEX $MTUS
0 replies
LiveLearnGrow Sep 26, 5:51 AM
$CVKD this one died, needs news.
1 replies
topstockalerts Sep 25, 11:47 PM
After Hours Top Gainers PT2 $CVKD $KOD $ACIU $CNET $GITS
0 replies
cfvk Sep 23, 8:14 PM
$CVKD eod Spike
1 replies